An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
about
Enhancement of Transgene Expression by HDAC Inhibitors in Mouse Embryonic Stem Cells.Histone deacetylase inhibitors restore cell surface expression of the coxsackie adenovirus receptor and enhance CMV promoter activity in castration-resistant prostate cancer cellsInnate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.Histone deacetylase inhibitors in the generation of the anti-tumour immune response.HDAC inhibitors in HIV.Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.Histone deacetylase inhibitors as immunomodulators in cancer therapeutics.An HDAC inhibitor enhances cancer therapeutic efficiency of RNA polymerase III promoter-driven IDO shRNA.Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells.
P2860
Q35246651-50880E49-2656-4184-B6EC-707B5122A2A3Q35687541-DA8036C9-FB09-490A-8A1C-818558BFC8C4Q36086345-BF9303AE-0111-4651-99B6-27E711BAB0A6Q37198835-8A46042C-F6E3-49E0-BB13-763DA2A1AFB1Q37579334-FDA96ACF-4F35-4D47-BC69-CAA46B4DAB83Q37953826-5B4B298F-CB8E-4763-9A8A-3F62592DD068Q37956178-3DEB2793-C792-4693-BE1F-4A4291695B82Q38537768-F101CB13-DB0B-48CD-9CA0-8BC560BC8489Q38763747-E31D1A24-C7C9-4843-B90D-25CE3363268AQ39150897-A8BE2232-9C34-4657-AF40-69E5F4812733Q39177415-D316FBAA-715D-43AB-95F7-E308116D6EBDQ50115667-698C79DE-2CED-46DF-940D-12CBF991302EQ54377524-50BEDA3A-1BF7-43B1-9859-44F7F7D0641F
P2860
An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
@en
An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
@nl
type
label
An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
@en
An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
@nl
prefLabel
An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
@en
An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
@nl
P2093
P2860
P356
P1433
P1476
An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2009.65
P50
P577
2009-10-23T00:00:00Z